Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the study record content; this indicates an access-related issue that blocks viewing the study details.SummaryDifference19%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small software/content update to the page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision indicator was updated to v3.6.5, replacing the previous v3.6.4, indicating a small release/maintenance update.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a backend or tooling update rather than a change to the visible study details.SummaryDifference0.0%

- Check78 days agoChange DetectedThe Publications section, including the PubMed-listed article and the auto-fill note about PubMed entries, has been removed from the study page. This reduces visible references and attribution for the study without altering core trial details.SummaryDifference0.2%

- Check93 days agoChange DetectedThe page's revision tag changed from v3.6.2 to v3.6.3, indicating an updated version of the page. This update does not modify the core study details or user-facing content beyond the version label.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.